Compare Mondaycom Ltd (MNDY) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mondaycom Ltd vs Regeneron Pharmaceuticals Inc — how do they compare? Mondaycom Ltd trades at $85.9 (market cap $3.70B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 22.2× Mondaycom Ltd's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.
| MNDY | REGN | |
|---|---|---|
Market Cap | $3.70B | $82.06B |
Sector | Technology | Health |
52-Week High | $219.15 | $812.27 |
52-Week Low | $58.81 | $555.51 |
Enterprise Value | $2.86B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
